2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia

OBJECTIVES: Parkinson’s disease and schizophrenia are clinical scenarios that occur due to dopaminergic deficit and hyperactivity in the midbrain, respectively. Current pharmacological interventions for these two diseases therefore aim to restore normal dopamine levels in the midbrain. But during th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ashish Kumar, Kumar, Gaurav Khunger, Rani, Komal, Pokhriyal, Ruchika, Khan, Mohd Imran, Kumar, Domada Ratna, Goyal, Vinay, Tripathi, Manjari, Gupta, Rishab, Chadda, Rakesh Kumar, Vanamail, Perumal, Mohanty, Ashok Kumar, Hariprasad, Gururao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488160/
https://www.ncbi.nlm.nih.gov/pubmed/31114209
http://dx.doi.org/10.2147/NDT.S198559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488160/
https://www.ncbi.nlm.nih.gov/pubmed/31114209
http://dx.doi.org/10.2147/NDT.S198559

Ejemplares similares